2002
DOI: 10.1111/j.1651-2227.2002.tb01729.x
|View full text |Cite
|
Sign up to set email alerts
|

Localized thigh swelling mimicking a neoplastic process: involvement of coxsackie virus type A21

Abstract: Dekel B, Yoeli R, Shulman L, Padeh S, Passwell JH. Localized thigh swelling mimicking a neoplastic process: involvement of coxsackie virus type A21. Acta P~diatr 2002; 91: 357-359. Stockholm. ISSN 0803-5253A 4-y-old girl was admitted because of a left leg limp with an isolated swollen upper thigh and normal muscle enzymes. A radioisotope scan showed increased uptake especially in the bone and soft tissue of the left thigh, while magnetic resonance imaging of that region demonstrated widespread oedema in striat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 7 publications
0
4
0
Order By: Relevance
“…Eventually the viremic animals succumb to generalized myositis, although this side effect is probably an artifact of the SCID mouse model since immunocompetent animals are known to be resistant to CVA21 myositis, 26 experimental CVA21 infections in humans cause little more than a short lived upper respiratory tract infection, 27 and only one human case of localized CVA21 myositis has been reported. 28 It will be interesting also to test the approach in an immunocompetent syngeneic mouse model but to date we have not been able to identify a mouse tumor that responds to CVA21 oncolytic virotherapy. The idea that INA coding for an oncolytic virus could be used for cancer therapy was formally proposed by Sutton in a letter to the Lancet in 1991.…”
Section: Discussionmentioning
confidence: 99%
“…Eventually the viremic animals succumb to generalized myositis, although this side effect is probably an artifact of the SCID mouse model since immunocompetent animals are known to be resistant to CVA21 myositis, 26 experimental CVA21 infections in humans cause little more than a short lived upper respiratory tract infection, 27 and only one human case of localized CVA21 myositis has been reported. 28 It will be interesting also to test the approach in an immunocompetent syngeneic mouse model but to date we have not been able to identify a mouse tumor that responds to CVA21 oncolytic virotherapy. The idea that INA coding for an oncolytic virus could be used for cancer therapy was formally proposed by Sutton in a letter to the Lancet in 1991.…”
Section: Discussionmentioning
confidence: 99%
“…CVA21 is a naturally occurring enterovirus that can induce mild infections of the upper respiratory tract in humans, but also myositis [156][157][158]. The virus is one of the most studied OV.…”
Section: Oncolytic Coxsackievirus B3 Versus Coxsackievirus A21mentioning
confidence: 99%
“…Although it is known to cause respiratory tract infections and myositis in humans [67, 68], its oncolytic potential has been proven in several cancer cell lines including MM [69, 70]. Intracellular adhesion molecule-1 (ICAM-1) and decay-accelerating factor are 2 receptors that are necessary for CVA21 infection and cell lysis, and both these are reported to be upregulated in cancer cells including MM in comparison to normal cells [69, 71].…”
Section: Viruses Used As Therapeutic Strategies For MMmentioning
confidence: 99%